What Founders Underestimate Early On
In this 60-minute session, Egbert Smit (CEO of MLA Diagnostics) and Annelies Rotthier (QbD Group) unpack the clinical evidence decisions that trip up oncology diagnostic startups — and how to get them right the first time.
In oncology IVD, the decisions you make earliest often cost you the most later. Intended use assumptions, sample strategy, study endpoints, these choices quietly shape your regulatory path, your timeline, and your credibility with investors.
Yet most founders only discover this when they're already locked in.
In this 60-minute session, Egbert Smit, CEO of MLA Diagnostics, and Annelies Rotthier from QbD Group unpack the clinical evidence decisions that trip up oncology diagnostic startups, and how to get them right the first time. Egbert brings the founder's perspective from building a melanoma risk stratification diagnostic. Annelies brings the strategic lens on study design and IVDR readiness.
No generic CRO talk. Just the early-stage thinking that separates fast, credible paths to market from expensive detours.
向最优秀的人学习
Two experts who've seen both sides of the oncology IVD journey — the founder's reality and the regulatory strategy that makes or breaks it.
CEO, MLA Diagnostics
Life sciences leader with 20+ years of science and business experience. (Co-)founder of several IVD businesses and currently leading oncology IVD venture MLA Diagnostics (Maastricht) and cardiovascular disease IVD venture PERSUASIVE (Utrecht).
Business Unit Manager IVD CRO, QbD Group
IVD Clinical Evidence and Medical Writing. IVD Product Development and IVDR Compliance. Strategic leadership & Consultancy.
Starts in
Is this for you?
Founders and CEOs of early-stage IVD/diagnostic companies
Regulatory affairs professionals in oncology diagnostics
Clinical evidence and study design leads
Quality managers at emerging medtech/IVD companies
Business development professionals in the IVD space
Keep watching
点播网络研讨会Join our webinar to explore the essential clinical evidence needed for success, including investigations, literature reviews, technical performance, and the use of similar devices. We’ll discuss the critical role of clinical validation starting from the design phase and guide you on how to compile the necessary evidence to meet MDR requirements.
立即观看
点播网络研讨会Learn how to design and deliver successful clinical performance studies under IVDR. Explore strategic, regulatory, and operational aspects with expert guidance.
立即观看